UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ApoA-I mimetics reduce systemic and gut inflammation in chronic treated HIV

PLoS pathogens, 2022-01, Vol.18 (1), p.e1010160

2022

Volltextzugriff (PDF)

NOTCH1 is a mechanosensor in adult arteries

Nature communications, 2017-11, Vol.8 (1), p.1620-19, Article 1620

2017

Volltextzugriff (PDF)

Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes

Diabetes (New York, N.Y.), 2011-10, Vol.60 (10), p.2617-2623

2011

Volltextzugriff (PDF)

Antiinflammatory Properties of HDL

Circulation Research, 2004-10, Vol.95 (8), p.764-872

2004

Volltextzugriff (PDF)

Endothelial NOTCH1 is suppressed by circulating lipids and antagonizes inflammation during atherosclerosis

The Journal of experimental medicine, 2015-11, Vol.212 (12), p.2147-2163

2015

Volltextzugriff (PDF)

Apolipoprotein A-I Mimetic Peptide 4F Rescues Pulmonary Hypertension by Inducing MicroRNA-193-3p

Circulation (New York, N.Y.), 2014-08, Vol.130 (9), p.776-785

2014

Volltextzugriff (PDF)

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

Journal of lipid research, 2008-06, Vol.49 (6), p.1344-1352

2008

Volltextzugriff (PDF)

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

Proceedings of the National Academy of Sciences - PNAS, 2010-11, Vol.107 (46), p.19997-20002

2010

Volltextzugriff (PDF)

Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis

Journal of lipid research, 2023-05, Vol.64 (5), p.100370-100370, Article 100370

2023

Volltextzugriff (PDF)

Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis

Journal of lipid research, 2015-04, Vol.56 (4), p.871-887

2015

Volltextzugriff (PDF)

Oxidized phospholipids cause changes in jejunum mucus that induce dysbiosis and systemic inflammation

Journal of lipid research, 2022-01, Vol.63 (1), p.100153, Article 100153

2022

Volltextzugriff (PDF)

Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice

Journal of lipid research, 2013-06, Vol.54 (6), p.1608-1615

2013

Volltextzugriff (PDF)

The role of dysfunctional HDL in atherosclerosis

Journal of lipid research, 2009-04, Vol.50 (Suppl), p.S145-S149

2009

Volltextzugriff (PDF)

HDL metabolism and activity in chronic kidney disease

Nature reviews. Nephrology, 2010-05, Vol.6 (5), p.287-296

2010

Volltextzugriff (PDF)

In memoriam: Judith A. Berliner, Ph.D

Journal of lipid research, 2022-04, Vol.63 (4), p.100180, Article 100180

2022

Volltextzugriff (PDF)

The paradox of dysfunctional high-density lipoprotein

Current opinion in lipidology, 2007-08, Vol.18 (4), p.427-434

2007

Volltextzugriff (PDF)

Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function[S]

Journal of lipid research, 2011-02, Vol.52 (2), p.361-373

2011

Volltextzugriff (PDF)

A novel approach to oral apoA-I mimetic therapy[S]

Journal of lipid research, 2013-04, Vol.54 (4), p.995-1010

2013

Volltextzugriff (PDF)

Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein Cholesterol levels and are favorably affected by simvastatin Treatment

Circulation (New York, N.Y.), 2003-12, Vol.108 (22), p.2751-2756

2003

Volltextzugriff (PDF)

Role of enterocyte stearoyl-Co-A desaturase-1 in LDLR-null mice

Journal of lipid research, 2018-10, Vol.59 (10), p.1818-1840

2018

Volltextzugriff (PDF)

Crosstalk between LXR and Toll-like Receptor Signaling Mediates Bacterial and Viral Antagonism of Cholesterol Metabolism

Molecular cell, 2003-10, Vol.12 (4), p.805-816

2003

Volltextzugriff (PDF)

Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux[S]

Journal of lipid research, 2016-07, Vol.57 (7), p.1175-1193

2016

Volltextzugriff (PDF)

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I

Journal of lipid research, 2008-11, Vol.49 (11), p.2302-2311

2008

Volltextzugriff (PDF)

Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD[S]

Journal of lipid research, 2016-05, Vol.57 (5), p.832-847

2016

Volltextzugriff (PDF)

Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties

Arteriosclerosis, thrombosis, and vascular biology, 2016-02, Vol.36 (2), p.274-284

2016

Volltextzugriff (PDF)

1 – 25 von 274

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(261)
Mit Volltextzugriff
(209)

Publikationsform

Sprache

Englisch
(274)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ApoA-I mimetics reduce systemic and gut inflammation in chronic treated HIV

NOTCH1 is a mechanosensor in adult arteries

Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes

Antiinflammatory Properties of HDL

Endothelial NOTCH1 is suppressed by circulating lipids and antagonizes inflammation during atherosclerosis

Apolipoprotein A-I Mimetic Peptide 4F Rescues Pulmonary Hypertension by Inducing MicroRNA-193-3p

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis

Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis

Oxidized phospholipids cause changes in jejunum mucus that induce dysbiosis and systemic inflammation

Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice

The role of dysfunctional HDL in atherosclerosis

HDL metabolism and activity in chronic kidney disease

In memoriam: Judith A. Berliner, Ph.D

The paradox of dysfunctional high-density lipoprotein

Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function[S]

A novel approach to oral apoA-I mimetic therapy[S]

Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein Cholesterol levels and are favorably affected by simvastatin Treatment

Role of enterocyte stearoyl-Co-A desaturase-1 in LDLR-null mice

Crosstalk between LXR and Toll-like Receptor Signaling Mediates Bacterial and Viral Antagonism of Cholesterol Metabolism

Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux[S]

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I

Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD[S]

Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties

Suchergebnisse filtern